Mostrando 141 - 160 Resultados de 1,135 Para Buscar 'Ashenden: OR the British Agent*', tiempo de consulta: 0.42s Limitar resultados
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
    “…By virtue of the involvement of DNA mismatch repair in modulating cytotoxic pathways in response to DNA damaging agents, we investigated the effects of loss of Pms2 on the sensitivity to a panel of widely used anticancer agents in E1A/Ha-Ras-transformed p53-null mouse fibroblasts either proficient or deficient in Pms2. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 148
    “…We report here that the cancer preventative agent resveratrol undergoes metabolism by the cytochrome P450 enzyme CYP1B1 to give a metabolite which has been identified as the known antileukaemic agent piceatannol. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 149
    “…Northern blot analyses revealed that, among the five agents examined, genistein had a strong inhibitory effect on expression of vascular endothelial growth factor mRNA and basic fibroblast growth factor mRNA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  10. 150
    por Wong, P, Kleemann, H-W, Tannock, I F
    Publicado 2002
    “…The agents inhibited the growth of tumour cells when they were incubated at low pHe (7.0–6.8), but were non-toxic to cells grown at doses that inhibited the regulation of pHi. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
    por Aft, R L, Zhang, F W, Gius, D
    Publicado 2002
    “…These data support the targeting of glucose metabolism as a site for chemotherapeutic intervention by agents such as 2-deoxy-D-glucose. British Journal of Cancer (2002) 87, 805–812. doi:10.1038/sj.bjc.6600547 www.bjcancer.com © 2002 Cancer Research UK…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  18. 158
    por Topaly, J, Fruehauf, S, Ho, A D, Zeller, W J
    Publicado 2002
    “…Imatinib did not potentiate the effects of irradiation or cytotoxic agents in BCR–ABL-negative cells. Our data provide the basis to further develop imatinib-containing conditioning therapies for stem cell transplantation in chronic myelogenous leukaemia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  19. 159
  20. 160
Herramientas de búsqueda: RSS